These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 2327369)
1. Variability in the fibrinogen and von Willebrand factor content of cryoprecipitate. Implications for reducing donor exposure. Hoffman M; Jenner P Am J Clin Pathol; 1990 May; 93(5):694-7. PubMed ID: 2327369 [TBL] [Abstract][Full Text] [Related]
2. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma. Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257 [TBL] [Abstract][Full Text] [Related]
3. Cryoprecipitate prepared from plasma frozen within 24 hours after phlebotomy contains acceptable levels of fibrinogen and VIIIC. Yazer MH; Triulzi DJ; Hassett AC; Kiss JE Transfusion; 2010 May; 50(5):1014-8. PubMed ID: 20003046 [TBL] [Abstract][Full Text] [Related]
4. Influence of canine donor plasma hemostatic protein concentration on quality of cryoprecipitate. Drinkhouse M; Brooks MB; Stefanovski D; Marryott K; Callan MB J Vet Intern Med; 2019 Jan; 33(1):124-131. PubMed ID: 30548342 [TBL] [Abstract][Full Text] [Related]
6. Can storage of thawed cryoprecipitate be extended to more than six hours? Saxena S; Odono V; Francis RB; Endahl GL; Shulman IA Am J Clin Pathol; 1990 Aug; 94(2):203-6. PubMed ID: 2115291 [TBL] [Abstract][Full Text] [Related]
7. Properties of a concentrated minipool solvent-detergent treated cryoprecipitate processed in single-use bag systems. Burnouf T; Caron C; Radosevich M; Goubran HA; Goudemand J; El-Ekiaby M Haemophilia; 2008 Sep; 14(5):956-62. PubMed ID: 18565126 [TBL] [Abstract][Full Text] [Related]
8. A Protocol for the Preparation of Cryoprecipitate and Cryo-depleted Plasma for Proteomic Studies. Sparrow RL; Simpson RJ; Greening DW Methods Mol Biol; 2017; 1619():23-30. PubMed ID: 28674874 [TBL] [Abstract][Full Text] [Related]
9. Hemostatic profile and safety of pooled cryoprecipitate up to 120 hours after thawing. Lokhandwala PM; O'Neal A; Patel EU; Brunker PAR; Gehrie EA; Zheng G; Kickler TS; Ness PM; Tobian AAR Transfusion; 2018 May; 58(5):1126-1131. PubMed ID: 29479708 [TBL] [Abstract][Full Text] [Related]
10. Comparison of albumin, colloid osmotic pressure, von Willebrand factor, and coagulation factors in canine cryopoor plasma, cryoprecipitate, and fresh frozen plasma. Culler CA; Iazbik C; Guillaumin J J Vet Emerg Crit Care (San Antonio); 2017 Nov; 27(6):638-644. PubMed ID: 29064153 [TBL] [Abstract][Full Text] [Related]
11. Extending the post-thaw viability of cryoprecipitate. Thomson C; Sobieraj-Teague M; Scott D; Duncan E; Abraham S; Roxby D Transfusion; 2021 May; 61(5):1578-1585. PubMed ID: 33728705 [TBL] [Abstract][Full Text] [Related]
12. Quantitative and qualitative analysis of coagulation factors in cryoprecipitate prepared from fresh-frozen plasma inactivated with amotosalen and ultraviolet A light. Cid J; Caballo C; Pino M; Galan AM; Martínez N; Escolar G; Diaz-Ricart M Transfusion; 2013 Mar; 53(3):600-5. PubMed ID: 22738354 [TBL] [Abstract][Full Text] [Related]
13. Preparation of Cryoprecipitate and Cryo-depleted Plasma for Proteomic Research Analysis. Sparrow RL; Simpson RJ; Greening DW Methods Mol Biol; 2023; 2628():41-49. PubMed ID: 36781778 [TBL] [Abstract][Full Text] [Related]
14. Hemostatic characteristics of thawed, pooled cryoprecipitate stored for 35 days at refrigerated and room temperatures. Fenderson JL; Meledeo MA; Rendo MJ; Peltier GC; McIntosh CS; Davis KW; Corley JB; Cap AP Transfusion; 2019 Apr; 59(S2):1560-1567. PubMed ID: 30980741 [TBL] [Abstract][Full Text] [Related]
15. Effect of cryoprecipitate and plasma on plasma von Willebrand factor multimeters and bleeding time in Doberman Pinschers with type-I von Willebrand's disease. Ching YN; Meyers KM; Brassard JA; Wardrop KJ Am J Vet Res; 1994 Jan; 55(1):102-10. PubMed ID: 8141483 [TBL] [Abstract][Full Text] [Related]
16. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system. Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of thawed pooled cryoprecipitate stored at refrigerated temperature for 24 hours. Soundar EP; Reyes M; Korte L; Bracey A Blood Transfus; 2018 Sep; 16(5):443-446. PubMed ID: 29106354 [TBL] [Abstract][Full Text] [Related]
18. Hemostatic capability of ultrafiltrated fresh frozen plasma compared to cryoprecipitate. Ichikawa J; Iba T; Okazaki R; Fukuda T; Kodaka M; Komori M; Levy JH Sci Rep; 2023 Dec; 13(1):21579. PubMed ID: 38062086 [TBL] [Abstract][Full Text] [Related]
19. Chromatographic preparation of a therapeutic highly purified von Willebrand factor concentrate from human cryoprecipitate. Burnouf-Radosevich M; Burnouf T Vox Sang; 1992; 62(1):1-11. PubMed ID: 1580062 [TBL] [Abstract][Full Text] [Related]